Victor Wang
Investor at StyleAI
Victor Wang
Investor at StyleAI
United States
Overview
Work Experience
Partner
2016 - Current
HOF Capital is a multi-stage venture capital firm with $1B+ in AUM. Backed by over 200 influential industry leaders, we look for relentlessly ambitious founders and help them build generational companies. Please refer to https://hofcapital.com/portfolio for a list of HOF Capital's portfolio companies.
HOF Capital is a global multistage VC firm with $1 billion in AUM that partners with ambitious entrepreneurs from idea to IPO.
First VC Investor & Board Observer
2022
Extropic is building the ultimate substrate for generative AI in the physical world by harnessing thermodynamic physics. The company is led by Guillaume Verdon (a.k.a. @BasedBeffJezos), the founder of the effective accelerationism (e/acc) movement and the former quantum ML lead at Google X. HOF Capital was the first VC firm to invest in Extropic, leading the company's pre-seed round.
Investor
2020
insitro uses AI and big data to transform the way that therapeutics are discovered and developed. The company was founded by Daphne Koller (the former CEO & founder of Coursera) and has raised $700M+ of total funding from investors like Andreessen Horowitz, ARCH Venture Partners, Bezos Expeditions, BlackRock, Casdin Capital, Foresite Capital, T. Rowe Price, Temasek, Two Sigma, and Google. insitro is now reportedly valued at $2.4B.
Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.
Raised $643,000,000.00 from Alexandria Venture Investments, BlackRock, HOF Capital, CPP Investments, Google Ventures, Foresite Capital, Casdin Capital, Temasek Holdings, T. Rowe Price and Third Rock Ventures.
First VC Investor & Board Director
2020
Motion provides AI-enabled productivity software for teams and individuals. The company is backed by Sam Altman (the CEO & founder of OpenAI), SignalFire, and Michael Seibel (the former CEO of Y Combinator). HOF Capital was the first VC firm to invest in Motion, leading the company's seed round.
Motion is an AI time management platform that provides real-time interventions, reminders, and analytics.
Raised $63,567,941.00 from Michael Seibel, Cyrus Mistry, Leonis Capital, 468 Capital, SignalFire, Sam Altman and HOF Capital.
Investor
2019
BillionToOne uses machine learning and next-generation sequencing to develop best-in-class non-invasive prenatal tests and liquid biopsy products. The company has grown its annualized revenue run rate from $0M to $125M in the last ~4 years and has raised nearly $400M of total funding from investors like Adams Street Partners, Baillie Gifford, Civilization Ventures, Fifty Years, Hummingbird Ventures, Neotribe Ventures, Neuberger Berman, Norwest Venture Partners, and Premji Invest. BillionToOne is now valued at $1B+.
BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.
Raised $425,900,000.00 from Baillie Gifford, Civilization Ventures, Neuberger Berman, Adams Street Partners, Libertus Capital, PremjiInvest, Hummingbird Ventures and Fifty Years.
First VC Lead Investor & Board Director
2023
StyleAI is building the all-in-one AI marketing platform for businesses, starting with AI-powered automation of search engine optimization, online advertising, and social media management. The company has grown from $0 to $4M+ of ARR in the first 12 months after its product launch. HOF Capital was the first VC firm to lead a funding round in the company.
Lead Investor & Board Director
2022
Intellect is the largest and fastest-growing mental health tech company founded in Asia, with over 3.5 million members and a Fortune Global 500 enterprise customer base that includes Dell, Hitachi, Merck, Kuehne+Nagel, Philips, Omnicom, Singtel, and Avery Dennison. The company is backed by leading global, regional, and strategic investors including Tiger Global, Headline, IHH Healthcare, MS&AD, East Ventures, and Insignia Venture Partners.
Researcher
2007 - 2007
The Stanford University School of Medicine has produced many of the innovations that sparked the biomedical revolution, including MRIs, gene splicing, and stem cell medicine. The Stanford Genome Technology Center develops new technologies to address important biological questions that otherwise would not be feasible to answer. Alumni of the Stanford Genome Technology Center include the founders of Guardant Health, Grail, and Counsyl.